136 related articles for article (PubMed ID: 27798836)
1. Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities.
Wang ZL; Pan JX; Song JJ; Tang HH; Yu HP; Li XH; Li N; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
J Med Chem; 2016 Nov; 59(22):10198-10208. PubMed ID: 27798836
[TBL] [Abstract][Full Text] [Related]
2. BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
Li N; Han ZL; Wang ZL; Xing YH; Sun YL; Li XH; Song JJ; Zhang T; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
Br J Pharmacol; 2016 Jun; 173(11):1864-80. PubMed ID: 27018797
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance.
Wang ZL; Li N; Wang P; Tang HH; Han ZL; Song JJ; Li XH; Yu HP; Zhang T; Zhang R; Xu B; Zhang MN; Fang Q; Wang R
Neuropharmacology; 2016 Sep; 108():364-72. PubMed ID: 26970017
[TBL] [Abstract][Full Text] [Related]
4. Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects.
Wang Z; Xu B; Jiang C; Zhang T; Zhang M; Li N; Zhang Q; Xu K; Chen D; Xiao J; Fang Q
J Pain; 2020; 21(3-4):477-493. PubMed ID: 31521796
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of the bifunctional opioid/neuropeptide FF receptors agonist BN-9 produced peripheral antinociception in preclinical mouse models of pain.
Li N; Han ZL; Xu B; Zhang MN; Zhang T; Shi XR; Zhao WD; Guo YY; Zhang QQ; Fang Q
Eur J Pharmacol; 2018 Oct; 837():53-63. PubMed ID: 30172787
[TBL] [Abstract][Full Text] [Related]
6. All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects.
Zhang M; Xu B; Li N; Zhang Q; Chen D; Wu S; Yu B; Zhang X; Hu X; Zhang S; Jing Y; Yang Z; Jiang J; Fang Q
J Med Chem; 2023 Dec; 66(24):17138-17154. PubMed ID: 38095323
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Characterization of Cyclic Disulfide-Containing Peptide Analogs of the Multifunctional Opioid/Neuropeptide FF Receptor Agonists That Produce Long-Lasting and Nontolerant Antinociception.
Zhang M; Xu B; Li N; Liu H; Shi X; Zhang Q; Shi Y; Xu K; Xiao J; Chen D; Zhu H; Sun Y; Zhang T; Zhang R; Fang Q
J Med Chem; 2020 Dec; 63(24):15709-15725. PubMed ID: 33271020
[TBL] [Abstract][Full Text] [Related]
8. OFP011 Cyclic Peptide as a Multifunctional Agonist for Opioid/Neuropeptide FF Receptors with Improved Blood-Brain Barrier Penetration.
Zhang M; Xu B; Li N; Zhang R; Zhang Q; Chen D; Rizvi SFA; Xu K; Shi Y; Yu B; Fang Q
ACS Chem Neurosci; 2022 Nov; 13(21):3078-3092. PubMed ID: 36262082
[TBL] [Abstract][Full Text] [Related]
9. Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects.
Zhang M; Xu B; Li N; Zhang R; Zhang Q; Shi X; Xu K; Xiao J; Chen D; Niu J; Shi Y; Fang Q
J Med Chem; 2021 Sep; 64(18):13394-13409. PubMed ID: 34465090
[TBL] [Abstract][Full Text] [Related]
10. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
[TBL] [Abstract][Full Text] [Related]
11. The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ- and κ-opioid receptors.
Xu B; Zhang M; Shi X; Zhang R; Chen D; Chen Y; Wang Z; Qiu Y; Zhang T; Xu K; Zhang X; Liedtke W; Wang R; Fang Q
Br J Pharmacol; 2020 Jan; 177(1):93-109. PubMed ID: 31444977
[TBL] [Abstract][Full Text] [Related]
12. Central and peripheral modulation of gastrointestinal transit in mice by DN-9, a multifunctional opioid/NPFF receptor agonist.
Xu B; Guo Y; Zhang M; Zhang R; Chen D; Zhang Q; Xiao J; Xu K; Li N; Qiu Y; Zhu H; Niu J; Zhang X; Fang Q
Neurogastroenterol Motil; 2020 Aug; 32(8):e13848. PubMed ID: 32281198
[TBL] [Abstract][Full Text] [Related]
13. Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation.
Zhang T; Han Z; Shi X; Zhao W; Wang Z; Zhang R; Xu B; Zhang M; Zhang Q; Xiao J; Zhu H; Zheng T; Fang Q
Bioorg Med Chem; 2019 Feb; 27(4):630-643. PubMed ID: 30626554
[TBL] [Abstract][Full Text] [Related]
14. NPYFa, A Chimeric Peptide of Met-Enkephalin, and NPFF Induces Tolerance-Free Analgesia.
Mudgal A; Kumar K; Mollereau C; Pasha S
Chem Biol Drug Des; 2016 Jun; 87(6):885-94. PubMed ID: 26802437
[TBL] [Abstract][Full Text] [Related]
15. Multitarget μ-Opioid Receptor Agonists─Neuropeptide FF Receptor Antagonists Induce Potent Antinociception with Reduced Adverse Side Effects.
De Neve J; Elhabazi K; Gonzalez S; Herby C; Schneider S; Utard V; Fellmann-Clauss R; Petit-Demouliere N; Lecat S; Kremer M; Ces A; Daubeuf F; Martin C; Ballet S; Bihel F; Simonin F
J Med Chem; 2024 May; 67(9):7603-7619. PubMed ID: 38687204
[TBL] [Abstract][Full Text] [Related]
16. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
17. Spinal administration of the multi-functional opioid/neuropeptide FF agonist BN-9 produced potent antinociception without development of tolerance and opioid-induced hyperalgesia.
Zhang R; Xu B; Zhang Q; Chen D; Zhang M; Zhao G; Xu K; Xiao J; Zhu H; Niu J; Li N; Fang Q
Eur J Pharmacol; 2020 Aug; 880():173169. PubMed ID: 32416184
[TBL] [Abstract][Full Text] [Related]
18. Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists.
Cheng MF; Ou LC; Chen SC; Chang WT; Law PY; Loh HH; Chao YS; Shih C; Yeh SH; Ueng SH
Bioorg Med Chem; 2014 Sep; 22(17):4694-703. PubMed ID: 25087049
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationships of a Novel Cyclic Hexapeptide That Exhibits Multifunctional Opioid Agonism and Produces Potent Antinociceptive Activity.
Zhang Q; Xu B; Chen D; Wu S; Hu X; Zhang X; Yu B; Zhang S; Yang Z; Zhang M; Fang Q
J Med Chem; 2024 Jan; 67(1):272-288. PubMed ID: 38118143
[TBL] [Abstract][Full Text] [Related]
20. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
Fang Q; Jiang TN; Li N; Han ZL; Wang R
Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
